CyberKnife for brain metastases of malignant melanoma and renal cell carcinoma

Neurosurgery

Volumn 64, Issue 2 SUPPL., 2009, Pages

  Hara, Wendy ^a,d   Tran, Phuoc ^a   Li, Gordon ^a   Su, Zheng ^b   Puataweepong, Putipun ^c   Adler Jr , John R ^a   Soltys, Scott G ^a   Chang, Steven D ^a   Gibbs, Iris C ^a  

^a STANFORD UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d STANFORD CANCER INSTITUTE   (United States)

Author keywords

Brain metastases; Melanoma; Radiosurgery; Renal cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION NECROSIS; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY; TUMOR VOLUME; WHOLE BODY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; MELANOMA; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 61449230650     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000339118.55334.EA     Document Type: Article

References (42)

1. Adler JR Jr, Murphy MJ, Chang SD, Hancock SL: Image-guided robotic radiosurgery. Neurosurgery 44:1299-1307, 1999.
2. Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B, Atkins M, Buzaid A, Skarlos D, Rankin EM: Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study. J Clin Oncol 22:2101-2107, 2004.
3. Antonadou D, Paraskevaidis M, Sarris G, Coliarakis N, Economou I, Karageorgis P, Throuvalas N: Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20:3644-3650, 2002.
4. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 295:2483-2491, 2006.
5. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL: Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 51:656-667, 2002.
6. Cannady SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, Barnett GH, Suh JH: Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study. Int J Radiat Oncol Biol Phys 58:253-258, 2004.
7. Chidel MA, Suh JH, Reddy CA, Chao ST, Lundbeck MF, Barnett GH: Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47:993-999, 2000.
8. Chougule PB, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G, Alderson L, Friehs G, Wazer D, Ebstein M: Randomized treatment of brain metastases with gamma knife, whole brain radiotherapy or both Int J Radiat Oncol Biol Phys 48:114, 2000 (abstr).
9. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989.
10. DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW: Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: Support for dose escalation based on a biological model. J Urol 158:746-749, 1997.
11. Ellerhorst J, Strom E, Nardone E, McCutcheon I: Whole brain irradiation for patients with metastatic melanoma: A review of 87 cases. Int J Radiat Oncol Biol Phys 49:93-97, 2001.
12. Feuvret L, Noel G, Mazeron JJ, Bey P: Conformity index: A review. Int J Radiat Oncol Biol Phys 64:333-342, 2006.
13. Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S: Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clin Proc 74:461-465, 1999.
14. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751, 1997.
15. Khuntia D, Brown P, Li J, Mehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:1295-1304, 2006.
16. Leibel SA (ed): Textbook of Radiation Oncology. Philadelphia, Saunders, 2004, p 934.
17. Manon R, O'Neill A, Knisely J, Wemer-Wasik M, Lazarus HM, Wagner H, Gilbert M, Mehta M: Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: An Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23:8870-8876, 2005.
18. Mehta MP, Khuntia D: Current strategies in whole-brain radiation therapy for brain metastases. Neurosurgery 57 [Suppl 5]:S33-S44, 2005.
19. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF: Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529-2536, 2003.
20. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L: The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37-46, 2005.
21. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD: Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581-589, 1998.
22. Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD: Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83:344-353, 1998.
23. Nieder C, Berberich W, Nestle U, Niewald M, Walter K, Schnabel K: Relation between local result and total dose of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 33:349-355, 1995.
24. Nieder C, Berberich W, Schnabel K: Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 39:25-30, 1997.
25. Ning S, Trisler K, Wessels BW, Knox SJ: Radiobiologic studies of radioim-munotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 80 [Suppl 12]:2519-2528, 1997.
26. Patchell RA: The management of brain metastases. Cancer Treat Rev 29:533-540, 2003.
27. Patchell RA, Regine WF: The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol Cancer Res Treat 2:111-115, 2003.
28. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M: Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563-3569, 1998.
29. Posner JB: Management of brain metastases. Rev Neurol (Paris) 148:477-487, 1992.
30. Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, Markert JM: Initial treatment of melanoma brain metastases using gamma knife radiosurgery: An evaluation of efficacy and toxicity. Cancer 101:825-833, 2004.
31. Rao G, Klimo P Jr, Thompson CJ, Samlowski W, Wang M, Watson G, Shrieve D, Jensen RL: Stereotactic radiosurgery as therapy for melanoma, renal carcinoma, and sarcoma brain metastases: Impact of added surgical resection and whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 66 [Suppl 4]: S20-S25, 2006.
32. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 52:333-338, 2002.
33. Rofstad EK: Radiation biology of malignant melanoma. Acta Radiol Oncol 25:1-10, 1986.
34. Roos DE, Wirth A, Burmeister BH, Spry NA, Drummond KJ, Beresford JA, McClure BE: Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol 80:318-322, 2006.
35. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291-298, 2000.
36. Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Fearlman A, Murray K, Caspar L, Mehta M, Curran W, Gerber M: RSR13 plus cranial radiation therapy in patients with brain metastases: Comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. I Clin Oncol 21:2364-2371, 2003.
37. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery in patients with renal cell carcinoma metastasis to the brain: Long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98:342-349, 2003.
38. Shimato S, Mitsudomi T, Kosaka T, Yatabe Y, Wakabayashi T, Mizuno M, Nakahara N, Hatano H, Natsume A, Ishii D, Yoshida ]: EGFR mutations in patients with brain metastases from lung cancer: Association with the efficacy of gefitinib. Neuro Oncol 8:137-144, 2006.
39. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA: Radiosurgery for brain metastases: Is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549-558, 1999.
40. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526, 2002.
41. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR, Brand R, Hermans J: Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583-590, 1993.
42. Wrónski M, Maor MH, Davis BJ, Sawaya R, Levin VA: External radiation of brain metastases from renal carcinoma: A retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37:753-759, 1997.